FBXO11 regulates bone development

被引:5
|
作者
Huang, Hong [1 ]
Lu, Jianrong [2 ]
Aukhil, Ikramuddin [1 ]
Yu, Colton [1 ]
Bhut, Brinda [1 ]
Marchesan, Julie [3 ]
Pirih, Flavia [4 ]
Chang, Jia [1 ]
机构
[1] Univ Florida, Dept Periodontol, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
[3] Univ North Carolina Chapel Hill, Adams Sch Dent, Div Comprehens Oral Hlth, Periodontol, Chapel Hill, NC 27599 USA
[4] UCLA Sch Dent, Sect Periodont, Los Angeles, CA 90095 USA
关键词
FBXO11; Snail1; Bone formation; Osteoblast; TRANSCRIPTION FACTORS; CRE RECOMBINASE; TRANSGENIC MICE; OTITIS-MEDIA; SEX STEROIDS; EXPRESSION; PROMOTER; VIT1/FBXO11; OSTEOBLASTS; APOPTOSIS;
D O I
10.1016/j.bone.2023.116709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FBXO11 is the substrate-recognition component of a ubiquitin ligase complex called SKP1-cullin-F-boxes. The role of FBXO11 in bone development is unexplored. In this study, we reported a novel mechanism of how bone development is regulated by FBXO11. FBXO11 gene knockdown by lentiviral transduction in mouse pre-osteoblast MC3T3-E1 cells leads to reduced osteogenic differentiation, while overexpressing FBXO11 acceler-ates their osteogenic differentiation in vitro. Furthermore, we generated two osteoblastic-specific FBXO11 conditional knockout mouse models, Col1a1-ERT2-FBXO11KO and Bglap2-FBXO11KO mice. In both conditional FBXO11KO mouse models, we found FBXO11 deficiency inhibits normal bone growth, in which the osteogenic activity in FBXO11cKO mice is reduced, while osteoclastic activity is not significantly changed. Mechanistically, we found FBXO11 deficiency leads to Snail1 protein accumulation in osteoblasts, leading to suppression of osteogenic activity and inhibition of bone matrix mineralization. FBXO11 knockdown in MC3T3-E1 cells reduced Snail1 protein ubiquitination and increased Snail1 protein accumulation in the cells, which eventually inhibited osteogenic differentiation. In conclusion, FBXO11 deficiency in osteoblasts inhibits bone formation through Snail1 accumulation, inhibiting osteogenic activity and bone mineralization.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] FBXO11 promotes the neddylation of p53 and inhibits its transcriptional activity
    Abida, Wassim M.
    Nikolaev, Anatoly
    Zhao, Wenhui
    Zhang, Wenzhu
    Gu, Wei
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (03) : 1797 - 1804
  • [22] De novo FBXO11 mutations are associated with intellectual disability, microcephaly and behavioural anomalies
    Kuechler, A.
    Fritzen, D.
    Becker, J.
    Peters, S.
    Sturm, M.
    Hundertmark, H.
    Schmidt, A.
    Kreiss, M.
    Strom, T.
    Wieczorek, D.
    Haack, T.
    Beck-Woedl, S.
    Cremer, K.
    Engels, H.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 228 - 229
  • [23] FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease
    Schneider, Christof
    Kon, Ning
    Amadori, Letizia
    Shen, Qiong
    Schwartz, Friederike H.
    Tischler, Benjamin
    Bossennec, Marion
    Dominguez-Sola, David
    Bhagat, Govind
    Gu, Wei
    Basso, Katia
    Dalla-Favera, Riccardo
    BLOOD, 2016, 128 (05) : 660 - 666
  • [24] FBXO11, a Regulator of BCL6 Stability, Is Recurrently Mutated in Burkitt Lymphoma
    Pighi, Chiara
    Compagno, Mara
    Wang, Qi
    Cheong, Taek-Chin
    Poggio, Teresa
    Langellotto, Fernanda
    di Celle, Paola Francia
    Zamo, Alberto
    Chiarle, Roberto
    BLOOD, 2015, 126 (23)
  • [25] Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity
    Bagger, Sofie Otzen
    Hopkinson, Branden Michael
    Pandey, Deo Prakash
    Bak, Mads
    Brydholm, Andreas Vincent
    Villadsen, Rene
    Helin, Kristian
    Ronnov-Jessen, Lone
    Petersen, Ole William
    Kim, Jiyoung
    MOLECULAR CANCER, 2018, 17
  • [26] FBXO11, a regulator of the TGFβ pathway, is associated with severe otitis media in Western Australian children
    M S Rye
    S P Wiertsema
    E S H Scaman
    J Oommen
    W Sun
    R W Francis
    W Ang
    C E Pennell
    D Burgner
    P Richmond
    S Vijayasekaran
    H L Coates
    S D Brown
    J M Blackwell
    S E Jamieson
    Genes & Immunity, 2011, 12 : 352 - 359
  • [27] Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma
    Bo Fan
    Wei Wang
    Xianping Zhang
    Min Sun
    Xiaogang Wang
    Zhiqi Chen
    Wankai Liu
    Qun Wang
    Na Yu
    Xiancheng Li
    BMC Cancer, 19
  • [28] De novo missense variants in FBXO11 alter its protein expression and subcellular localization
    Gregor, Anne
    Meerbrei, Tanja
    Gerstner, Thorsten
    Toutain, Annick
    Lynch, Sally Ann
    Stals, Karen
    Maxton, Caroline
    Lemke, Johannes R.
    Bernat, John A.
    Bombei, Hannah M.
    Foulds, Nicola
    Hunt, David
    Kuechler, Alma
    Beygo, Jasmin
    Stobe, Petra
    Bouman, Arjan
    Palomares-Bralo, Maria
    Santos-Simarro, Fernando
    Garcia-Minaur, Sixto
    Pacio-Miguez, Marta
    Popp, Bernt
    Vasileiou, Georgia
    Hebebrand, Moritz
    Reis, Andre
    Schuhmann, Sarah
    Krumbiegel, Mandy
    Brown, Natasha J.
    Sparber, Peter
    Melikyan, Lyusya
    Bessonova, Liudmila
    Cherevatova, Tatiana
    Sharkov, Artem
    Shcherbakova, Natalia
    Dabir, Tabib
    Kini, Usha
    Schwaibold, Eva M. C.
    Haack, Tobias B.
    Bertoli, Marta
    Hoffjan, Sabine
    Falb, Ruth
    Shinawi, Marwan
    Sticht, Heinrich
    Zweier, Christiane
    HUMAN MOLECULAR GENETICS, 2022, 31 (03) : 440 - 454
  • [29] Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
    Pighi, Chiara
    Cheong, Taek-Chin
    Compagno, Mara
    Patrucco, Enrico
    Arigoni, Maddalena
    Olivero, Martina
    Wang, Qi
    Lopez, Cristina
    Bernhart, Stephan H.
    Grande, Bruno M.
    Poggio, Teresa
    Langellotto, Fernanda
    Bonello, Lisa
    Dall'Olio, Riccardo
    Martinez-Martin, Sandra
    Molinaro, Luca
    di Celle, Paola Francia
    Whitfield, Jonathan R.
    Soucek, Laura
    Voena, Claudia
    Calogero, Raffaele A.
    Morin, Ryan D.
    Staudt, Louis M.
    Siebert, Reiner
    Zamo, Alberto
    Chiarle, Roberto
    BLOOD ADVANCES, 2021, 5 (23) : 5239 - 5257
  • [30] The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote Tumorigenesis
    Yang, Chuan He
    Pfeffer, Susan R.
    Sims, Michelle
    Yue, Junming
    Wang, Yinan
    Linga, Vijay G.
    Paulus, Elena
    Davidoff, Andrew M.
    Pfeffer, Lawrence M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (10) : 6037 - 6046